Decoy Therapeutics, Inc. (DCOY)
2.92
-0.06
(-2.01%)
USD |
NASDAQ |
Sep 03, 16:00
2.92
0.00 (0.00%)
After-Hours: 17:35
Decoy Therapeutics Research and Development Expense (Annual) : 0.3682M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.3682M |
| December 31, 2024 | 0.77M |
| December 31, 2023 | 7.174M |
| December 31, 2022 | 15.84M |
| December 31, 2021 | 8.548M |
| December 31, 2020 | 6.914M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.019M |
| December 31, 2018 | 1.288M |
| December 31, 2017 | 16.99M |
| December 31, 2016 | 20.38M |
| December 31, 2015 | 12.75M |
| December 31, 2014 | 4.004M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Palatin Technologies, Inc. | 14.90M |
| Unicycive Therapeutics, Inc. | 9.121M |
| Nuvectis Pharma, Inc. | 18.15M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |